Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified April 2012 by ikfe-CRO GmbH.
Recruitment status was:  Recruiting
Sponsor:
Collaborators:
ikfe-CRO GmbH
Boehringer Ingelheim
Information provided by (Responsible Party):
Marcus Borchert, ikfe-CRO GmbH
ClinicalTrials.gov Identifier:
NCT01547104
First received: February 21, 2012
Last updated: April 10, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2012
  Estimated Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)